Carsten Brockmeyer
Carsten Brockmeyer is CEO of Formycon AG in Martinsried, Germany.
False
Advertisement
The Monoclonal Milestone
December 1, 2014
The launch of the world’s first biosimilar monoclonal antibody was a big step forward from a regulatory and scientific standpoint. Will there be enough room at the table?
0 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
